A PHASE-II STUDY OF BISANTRENE IN RELAPSING OR REFRACTORY ACUTE NONLYMPHOBLASTIC LEUKEMIAS

被引：0
|
作者：
ISNARD, F
MARTY, M
GISSELBRECHT, C
ESPIE, M
MARAL, J
BOIRON, M
机构：
[1] HOP ST LOUIS,PHARMACOL CLIN ANTICANC GRP,F-75475 PARIS 10,FRANCE
[2] LEDERLE LABS,PARIS,FRANCE
来源：
INVESTIGATIONAL NEW DRUGS | 1987年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [1] PHASE-II STUDY OF BISANTRENE IN RELAPSED REFRACTORY ACUTE NON LYMPHOID LEUKEMIAS (ANLL)
    TOSI, P
    VISANI, G
    COLOMBINI, R
    VERLICCHI, F
    BENFENATI, D
    CENACCHI, A
    RUSSO, D
    ZUFFA, E
    PAPADOPULU, P
    TURA, S
    HAEMATOLOGICA, 1989, 74 (06) : 555 - 558
  • [2] A PHASE-II STUDY OF BISANTRENE IN ANLL
    MARTY, M
    CLARK, MJ
    COLLADO, S
    CALVO, F
    GISSELBRECHT, C
    SCHAISON, G
    LAPORTE, JP
    NGUYENDINH, C
    BOIRON, M
    THERAPIE, 1986, 41 (06): : 523 - 523
  • [3] PHASE-I STUDY OF BISANTRENE IN ACUTE NONLYMPHOBLASTIC LEUKEMIA
    MARTY, M
    FERME, C
    GISSELBRECHT, C
    GUY, H
    CLARK, MJ
    BANCILLON, A
    BOIRON, M
    CANCER TREATMENT REPORTS, 1985, 69 (06): : 703 - 705
  • [4] PHASE-II EVALUATION OF BISANTRENE HYDROCHLORIDE IN REFRACTORY MALIGNANT-MELANOMA
    ALBERTS, DS
    MASONLIDDIL, N
    GREEN, SJ
    COWAN, JD
    FLETCHER, WS
    NEILAN, B
    GUY, JT
    EPSTEIN, RB
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (03) : 289 - 292
  • [5] A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia
    Canaani, Jonathan
    Danylesko, Ivetta
    Shemtov, Noga
    Zlotnick, Maya
    Lozinsky, Kira
    Benjamini, Ohad
    Yerushalmi, Ronit
    Nagar, Meital
    Dor, Chen
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (02) : 260 - 266
  • [6] A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Canaani, Jonathan
    Danilesko, Ivetta
    Shem-Tov, Noga
    Zlotnick, Maya
    Lozinsky, Kira
    Benjamini, Ohad
    Yerushalmi, Ronit
    Nagar, Meital
    Dor, Chen
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    BLOOD, 2020, 136
  • [7] PHASE-II STUDY OF BISANTRENE IN ADVANCED MALIGNANT-MELANOMA
    PAPADOPOULOS, NEJ
    TENNEY, DM
    CHAWLA, S
    PLAGER, C
    BENJAMIN, RS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 174 - 174
  • [8] PHASE-II EVALUATION OF BISANTRENE IN REFRACTORY MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    DURIE, BGM
    CROWLEY, J
    COLTMAN, CA
    CHAPMAN, RA
    BALCERZK, SP
    BONNET, JD
    LIPSCHITZ, DA
    STEPHENS, RL
    CHESON, BD
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (04) : 329 - 331
  • [9] PHASE-II EVALUATION OF BISANTRENE IN ACUTE-LEUKEMIA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    MILLS, GM
    DAHLBERG, S
    COWAN, J
    NEILAN, BA
    GUMBART, CH
    HUSSEIN, K
    COLTMAN, CA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (06): : 507 - 510
  • [10] A PHASE-II STUDY OF POLYETHYLENE-GLYCOL (PEG) CONJUGATED L-ASPARAGINASE IN PATIENTS WITH REFRACTORY ACUTE LEUKEMIAS
    KURTZBERG, J
    MOORE, JO
    SCUDIERY, D
    FRANKLIN, A
    BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1988, 15 (04): : 772 - 772
12345